The antibody 34bE12, available from A Menarini Diagnostics, recognises cytokeratin 1, 5, 10 and 14. It reacts with squamous and adenosquamous cell carcinomas, while adenocarcinoma is negative. In normal tissue, 34bE12 stains stratified epithelia, myoepithelial cells and basal cells in the prostate gland and bronchus. Thus, it is useful as a differential marker for squamous carcinoma and adenocarcinoma as well as for benign and malignant tumours of the prostate gland.
Other News
Latest Issues
UK NEQAS IMPROVES PATIENT CARE
We aim to improve patient care through monitoring the quality of tests and their reporting, in an independent manner and on a not-for-profit basis.
We are here to help ensure optimal quality in testing for the benefit of patients.
We believe that the result of tests should be:
IHC applications in laboratory practice webinar
Online
11-13 November, 2025
BAC Annual Scientific Meeting 2025
Online
20 November, 2025
Transmission electron microscopy webinar
Online
25 November, 2025
UK NEQAS for Microbiology Annual Scientific Meeting
The Royal National Hotel, 38 – 51 Bedford Way, London, WC1H 0DG
28 November, 2025
Introduction to bone marrow trephine
Online
9 December, 2025